Zobrazeno 1 - 10
of 56 580
pro vyhledávání: '"DIABETIC-NEPHROPATHY"'
Autor:
Farhana Begum, Karpagavel Lakshmanan
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Diabetes mellitus and its complications exploit significantly impact global human well-being and economic burden. Previous studies and clinical trials have provided insights into the concept of metabolic memory, which sustains even after hyp
Externí odkaz:
https://doaj.org/article/8e4a6a0d46f44540912e6252eab2fe2d
Autor:
Farhana Begum, Karpagavel Lakshmanan
Publikováno v:
Egyptian Journal of Medical Human Genetics, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Microvascular complications of diabetes including retinopathy, nephropathy, and neuropathy are those long-term complications that affect small blood vessels. Diabetic nephropathy (DN) is characterized by persistent microalbuminuri
Externí odkaz:
https://doaj.org/article/32b1dc7b43ba4aba9ee3b46b410bd57d
Autor:
Xiao-Meng Shan, Chun-Wei Chen, Da-Wei Zou, Yan-Bin Gao, Yin-Ying Ba, Jia-Xin He, Zhi-Yao Zhu, Jia-Jun Liang
Publikováno v:
Chinese Medicine, Vol 19, Iss 1, Pp 1-17 (2024)
Abstract Background Tangshenning (TSN) is a safe and effective formula to treat diabetic nephropathy (DN), and clinical studies have demonstrated that its therapeutic effects are related to oxidative stress improvements in patients. Herein, this stud
Externí odkaz:
https://doaj.org/article/341dd6e0b319432e81fa8b84ff2fd942
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-12 (2024)
Abstract Objective Accumulation of extracellular matrix (ECM) proteins in the glomerular mesangial region is a typical hallmark of diabetic nephropathy (DN). However, the molecular mechanism underlying ECM accumulation in the mesangium of DN patients
Externí odkaz:
https://doaj.org/article/b7de771b463746229504589422e7b003
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-10 (2024)
Abstract Folates play a crucial role as cofactors in metabolic pathways, influencing biological methylation and nucleotide synthesis, which has a significant impact on overall health and disease susceptibility. Diabetic nephropathy (DN) is a prevalen
Externí odkaz:
https://doaj.org/article/8c0062c84eb6419797f3e040fdac0fe4
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-11 (2024)
Abstract Objective Previous observational studies have indicated associations between various inflammatory cytokines and diabetic nephropathy (DN) caused by type 2 diabetes mellitus (T2DM). However, the causality remains unclear. We aimed to further
Externí odkaz:
https://doaj.org/article/63b87244801749e09550e9a52a415ad2
Autor:
Zongchao Yu, Yongping Lu, Mengxian Zhang, Yanshan Lin, Tak-sui Wong, Baozhang Guan, Yu Meng, Bo Hu, Fan-na Liu, Lianghong Yin, Yankun Li, Han Zhang, Donge Tang, Yong Dai
Publikováno v:
Proteome Science, Vol 22, Iss 1, Pp 1-11 (2024)
Abstract Diabetic nephropathy affects a significant proportion of individuals with diabetes, and its progression often leads to cardiovascular disease and infections before the need for renal replacement therapy arises. Empagliflozin has been shown t
Externí odkaz:
https://doaj.org/article/27554417ffd04b9f934c75126b1d18d3
Publikováno v:
Molecular Medicine, Vol 30, Iss 1, Pp 1-16 (2024)
Abstract Background We previously reported aberrant expression of the cytosolic ribosomal biogenesis factor Nop-7-associated 2 (NSA2) in diabetic nephropathy, the latter also known to involve mitochondrial dysfunction, however the connections between
Externí odkaz:
https://doaj.org/article/7e08de0f74b64767b33c5535ab704ad2
Publikováno v:
BMC Public Health, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Weight control has consistently been regarded as a significant preventive measure against diabetic nephropathy. however, the potential impact of substantial fluctuations in body fat during this process on the risk of diabetic neph
Externí odkaz:
https://doaj.org/article/9eca9dccc0a342c08e9503f9695aa840
Autor:
Sunagawa K, Hirai K, Sunagawa S, Kamiya N, Komesu I, Sunagawa Y, Sunagawa H, Nakachi K, Hirai A, Ookawara S, Morishita Y
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity, Vol Volume 17, Pp 3767-3781 (2024)
Kae Sunagawa,1,2 Keiji Hirai,3 Sumito Sunagawa,1,2 Norifumi Kamiya,1 Isao Komesu,1 Yusako Sunagawa,1 Hiroshi Sunagawa,1 Ken Nakachi,4 Aizan Hirai,5 Susumu Ookawara,3 Yoshiyuki Morishita3 1Sunagawa Medical Clinic, Okinawa, Japan; 2Division of Endocrin
Externí odkaz:
https://doaj.org/article/310c83a1ef4f4dd4a7012a977f9d4501